2018Journal of Veterinary Pharmacology and TherapeuticsOpen access

Expression of functional TRPV 1 receptor in primary culture of canine keratinocytes

Raffaella Barbero, Cristina Vercelli, B. Cuniberti, Maria Federica della Valle, Marina Martano, Re G

Open full text 10 citations

Abstract

Abstract The interest for the endovanilloid system and for transient receptor potential vanilloid 1 (TRPV1) is continuously increasing, due to their involvement in inflammation, nociception and pruritus. Even ifTRPV1 enrolment was highlighted in both physiological and pathological conditions, some aspects remain unclear, mostly in veterinary medicine. This study aimed to verify the expression and functionality ofTRPV1 in canine keratinocytes to investigate in vitro the role ofTRPV1 in these cells that are involved in different cutaneous pathologies. Keratinocytes primary cultures were isolated from bioptical samples and cultivated. Binding assay (using3[H]‐resiniferatoxin), displacement assay (in the presence of 1.2 nM3[H]‐resiniferatoxin) and functional assays (in the presence of 1 μCi/45Ca2+) with vanilloid agonists and antagonists, specifically addressed toTRPV1 receptor, were performed. Binding assay demonstrated the presence of measurable concentrations ofTRPV1 (Bmax = 1,240 ± 120 fmol/mg protein;Kd = 0.01 ± 0.004 nM). Displacement assay highlighted the highest affinity for resiniferatoxin (RTX) and 5‐iodo‐resiniferatoxin (5‐I‐RTX), among agonists and antagonists, respectively. The same compounds results as the most potent in the functional assays. This study demonstrated the identification and the characterization ofTRPV1 receptor in primary canine keratinocytes cultures. The results are promising for a clinical use, but further in vivo investigations are required.

About this research paper

What this paper is about

Abstract The interest for the endovanilloid system and for transient receptor potential vanilloid 1 (TRPV1) is continuously increasing, due to their involvement in inflammation, nociception and pruritus. Even ifTRPV1 enrolment was highlighted in both physiological and pathological conditions, some aspects remain unclear, mostly in veterinary medicine. This study aimed to verify the expression and functionality ofTRPV1 in canine keratinocytes to investigate in vitro the role ofTRPV1 in these cells that are involved in different cutaneous pathologies. Keratinocytes primary cultures were isolated from bioptical samples and cultivated. Binding assay (using3[H]‐resiniferatoxin), displacement assay (in the presence of 1.2 nM3[H]‐resiniferatoxin) and functional assays (in the presence of 1 μCi/45Ca2+) with vanilloid agonists and antagonists, specifically addressed toTRPV1 receptor, were performed. Binding assay demonstrated the presence of measurable concentrations ofTRPV1 (Bmax = 1,240 ± 120 fmol/mg protein;Kd = 0.01 ± 0.004 nM). Displacement assay highlighted the highest affinity for resiniferatoxin (RTX) and 5‐iodo‐resiniferatoxin (5‐I‐RTX), among agonists and antagonists, respectively. The same compounds results as the most potent in the functional assays. This study demonstrated the identification and the characterization ofTRPV1 receptor in primary canine keratinocytes cultures. The results are promising for a clinical use, but further in vivo investigations are required.

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract The interest for the endovanilloid system and for transient receptor potential vanilloid 1 (TRPV1) is continuously increasing, due to their involvement in inflammation, nociception and pruritus. Even ifTRPV1 enrolment was highlighted in both physiological and pathological conditions, some aspects remain unclear, mostly in veterinary medicine. This study aimed to verify the expression and functionality ofTRPV1 in canine keratinocytes to investigate in vitro the role ofTRPV1 in these cells that are involved in different cutaneous pathologies. Keratinocytes primary cultures were isolated from bioptical samples and cultivated. Binding assay (using3[H]‐resiniferatoxin), displacement assay (in the presence of 1.2 nM3[H]‐resiniferatoxin) and functional assays (in the presence of 1 μCi/45Ca2+) with vanilloid agonists and antagonists, specifically addressed toTRPV1 receptor, were performed. Binding assay demonstrated the presence of measurable concentrations ofTRPV1 (Bmax = 1,240 ± 120 fmol/mg protein;Kd = 0.01 ± 0.004 nM). Displacement assay highlighted the highest affinity for resiniferatoxin (RTX) and 5‐iodo‐resiniferatoxin (5‐I‐RTX), among agonists and antagonists, respectively. The same compounds results as the most potent in the functional assays. This study demonstrated the identification and the characterization ofTRPV1 receptor in primary canine keratinocytes cultures. The results are promising for a clinical use, but further in vivo investigations are required.

Key concepts: Resiniferatoxin, TRPV, Chemistry, Pharmacology, Receptor, Agonist, Transient receptor potential channel, Biochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of functional TRPV 1 receptor in primary culture of canine keratinocytes — Research Paper | ScholarLens